226916-19-4 Usage
Uses
Used in Pharmaceutical Industry:
(E)-3-(1,4-DIOXASPIRO[4.5]DEC-7-EN-7-YL)ACRYLIC ACID is used as a key intermediate in the synthesis of novel pharmaceuticals for its unique reactivity and structural properties, which can contribute to the development of new drugs with enhanced efficacy and selectivity.
Used in Agrochemical Industry:
In the agrochemical sector, (E)-3-(1,4-DIOXASPIRO[4.5]DEC-7-EN-7-YL)ACRYLIC ACID serves as a vital component in the creation of innovative agrochemicals, leveraging its unique properties to improve the performance and selectivity of pesticides and other agricultural chemicals.
Used in Advanced Material Science:
(E)-3-(1,4-DIOXASPIRO[4.5]DEC-7-EN-7-YL)ACRYLIC ACID is utilized as a building block in the development of advanced materials, such as polymers and composites, due to its distinctive spirocycle structure that can impart unique characteristics to these materials, enhancing their performance in various applications.
Used in Organic Chemistry Research:
As a versatile chemical compound, (E)-3-(1,4-DIOXASPIRO[4.5]DEC-7-EN-7-YL)ACRYLIC ACID is employed as a research tool in organic chemistry, facilitating the exploration of new reaction pathways and the synthesis of complex organic molecules for academic and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 226916-19-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,6,9,1 and 6 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 226916-19:
(8*2)+(7*2)+(6*6)+(5*9)+(4*1)+(3*6)+(2*1)+(1*9)=144
144 % 10 = 4
So 226916-19-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H14O4/c12-10(13)4-3-9-2-1-5-11(8-9)14-6-7-15-11/h2-4H,1,5-8H2,(H,12,13)/b4-3+
226916-19-4Relevant academic research and scientific papers
Metabolism-based identification of a potent thrombin receptor antagonist
Clasby, Martin C.,Chackalamannil, Samuel,Czarniecki, Michael,Doller, Dario,Eagen, Keith,Greenlee, William,Kao, Grace,Lin, Yan,Tsai, Hsingan,Xia, Yan,Ahn, Ho-Sam,Agans-Fantuzzi, Jacqueline,Boykow, George,Chintala, Madhu,Foster, Carolyn,Smith-Torhan, April,Alton, Kevin,Bryant, Matthew,Hsieh, Yunsheng,Lau, Janice,Palamanda, Jairam
, p. 129 - 138 (2008/02/03)
The metabolism of our prototypical thrombin receptor antagonist 1, K i = 2.7 nM, was studied and three major metabolites (2, 4, and 5) were found. The structures of the metabolites were verified independently by synthesis. Compound 4 was shown
PREPARATION OF CHIRAL PROPARGYLIC ALCOHOL AND ESTER INTERMEDIATES OF HIMBACINE ANALOGS
-
Page/Page column 39, (2008/06/13)
This application discloses a novel process for the conversion of a series of racemic propargylic alcohols to corresponding (R)-enantiomers. The application also discloses the enantio-selective esterification of a propargylic alcohol from its racemate to p
THROMBIN RECEPTOR ANTAGONISTS
-
Page 100, (2010/11/30)
Heterocyclic-substituted tricyclics of formula (I) or a pharmaceutically acceptable salt thereof, wherein: the single dotted line represents an optional double bond; the double dotted line represents an optional single bond; n is 0-2; Q is optionally subs
